pembrolizumab
merck
['nhl', 'pembro']
dr. jacobsen presents data on pembro post auto hct in t cell nhl, phase 2, median pfs 30m, 18m estimated pfs 83%, most completed 8 cycles. good results! #ash22 
Hem/Onc, BMT, CAR-T, Immunology, Math, Machine Learning, Python, R, SAS. Tweets are my personal views